Basic Information
Basic information for MKLN1-AS-210-44aa
Peptide Name MKLN1-AS-210-44aa
Genome Position chr7:131323686-131323817[-]
Species Human
Peptide Sequence MIIGNNDQKWGSFDIPKVIYLCTPLERAGFRTRHVNKRLTSTGT
Peptide Length 44
Unique No (MKLN1-AS-201-44aa,MKLN1-AS-202-44aa,MKLN1-AS-203-44aa,MKLN1-AS-205-44aa,MKLN1-AS-206-44aa,MKLN1-AS-207-44aa,MKLN1-AS-208-44aa,MKLN1-AS-209-44aa,MKLN1-AS-211-44aa,MKLN1-AS-212-44aa,MKLN1-AS-213-44aa,MKLN1-AS-214-44aa,MKLN1-AS-215-44aa,MKLN1-AS-216-44aa)
Grand Average of Hydropathicity -0.4523
Relative Molecular Mass 5810.63
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000236753;MKLN1-AS
Transcript ID/Name ENST00000655177;MKLN1-AS-210
Transcript Length 2191
Coding Ability 0.2656
DNA Sequence Corresponding to Peptide ATGATCATAGGCAACAATGACCAAAAATGGGGATCTTTTGATATACCTAAAGTAATTTATTTGTGCACACCATTGGAAAGAGCTGGTTTTAGAACCAGACATGTAAATAAGAGACTGACTTCCACTGGCACC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :